{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:42:41Z","timestamp":1790959361945,"version":"4.1.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Finasteride has been associated with sexual side effects that may persist despite discontinuation of the medication. In a clinical series, 20% of subjects with male pattern hair loss reported persistent sexual dysfunction for \u22656 years, suggesting the possibility that the dysfunction may be permanent. These subjects also reported a wide range of symptoms including changes in cognition, ejaculate quality, and genital sensation. Other medications have been associated with irreversible neurological effects, such as phenothiazines with tardive dyskinesias.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To prospectively study whether the persistent sexual side effects associated with finasteride resolve or endure over time.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Subjects (N = 54) with persistent sexual side effects associated with finasteride were reassessed after 9\u201316 months (mean 14 months). All subjects were otherwise healthy young men without any baseline sexual dysfunction, medical conditions, psychiatric conditions, or use of oral prescription medications prior to taking finasteride for male pattern hair loss.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measure<\/jats:title>\n                  <jats:p>Scores from the Arizona Sexual Experience Scale (ASEX).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The participation rate was 81%. At reassessment persistent sexual side effects continued to be present in 96% of subjects. According to the ASEX scores, 89% of subjects met the definition of sexual dysfunction. Neither the length of finasteride use nor the duration of the sexual side effects correlated to changes in scores of sexual dysfunction.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In most men who developed persistent sexual side effects (\u22653 months) despite the discontinuation of finasteride, the sexual dysfunction continued for many months or years. Although several rat studies have shown detrimental changes to erectile function caused by 5 alpha reductase inhibitors, the persistent nature of these changes is an area of active research. Prescribers of finasteride and men contemplating its use should be made aware of the potential adverse medication effects.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2012.02846.x","type":"journal-article","created":{"date-parts":[[2012,7,13]],"date-time":"2012-07-13T08:11:35Z","timestamp":1342167095000},"page":"2927-2932","source":"Crossref","is-referenced-by-count":131,"title":["Persistent Sexual Side Effects of Finasteride: Could They be Permanent?"],"prefix":"10.1093","volume":"9","author":[{"given":"Michael S.","family":"Irwig","sequence":"first","affiliation":[{"name":"Center for Andrology and Division of Endocrinology, The George Washington University , Washington, DC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,11,1]]},"reference":[{"key":"2024032600301391900_bb0010","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0190-9622(98)70007-6","article-title":"Finasteride in the treatment of men with androgenetic alopecia: Finasteride Male Pattern Hair Loss Study Group","volume":"39","author":"Kaufman","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"2024032600301391900_bb0015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00003495-199957010-00014","article-title":"Finasteride: A review of its use in male pattern hair loss","volume":"57","author":"McClellan","year":"1999","journal-title":"Drugs"},{"key":"2024032600301391900_bb0020","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jaad.2006.05.007","article-title":"The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride","volume":"55","author":"Olsen","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"2024032600301391900_bb0025","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/j.1743-6109.2011.02255.x","article-title":"Persistent sexual side effects of finasteride for male pattern hair loss","volume":"8","author":"Irwig","year":"2011","journal-title":"J Sex Med"},{"key":"2024032600301391900_bb0030","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1743-6109.2010.02157.x","article-title":"Adverse side effects of 5\u03b1-reductase inhibitors therapy: Persistent diminished libido and erectile dysfunction and depression in a subset of patients","volume":"8","author":"Traish","year":"2011","journal-title":"J Sex Med"},{"key":"2024032600301391900_bb0035","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/SMJ.0b013e3181f5ecb5","article-title":"Adverse drug reactions: Part II","volume":"103","author":"Wooten","year":"2010","journal-title":"South Med J"},{"key":"2024032600301391900_bb0040"},{"key":"2024032600301391900_bb0045","first-page":"758","article-title":"Apparently irreversible syndrome of abnormal movements following phenothiazine medication","volume":"57","author":"Hunter","year":"1964","journal-title":"Proc R Soc Med"},{"key":"2024032600301391900_bb0050","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2613.2008.00618.x","article-title":"Long-term inhibition of 5-alpha reductase and aromatase changes the cellular and extracellular compartments in gerbil ventral prostate at different postnatal ages","volume":"90","author":"Corradi","year":"2009","journal-title":"Int J Exp Pathol"},{"key":"2024032600301391900_bb0055","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-0030-1249095","article-title":"Finasteride treatment inhibits adult hippocampal neurogenesis in male mice","volume":"43","author":"R\u00f6mer","year":"2010","journal-title":"Pharmacopsychiatry"},{"key":"2024032600301391900_bb0060","doi-asserted-by":"crossref","first-page":"8209","DOI":"10.1073\/pnas.0306631101","article-title":"Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins","volume":"101","author":"Charalampopoulos","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024032600301391900_bb0065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/009262300278623","article-title":"The Arizona Sexual Experience Scale (ASEX): Reliability and validity","volume":"26","author":"McGahuey","year":"2000","journal-title":"J Sex Marital Ther"},{"key":"2024032600301391900_bb0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.ijir.3901591","article-title":"Assessment of sexual function\/dysfunction via patient reported outcomes","volume":"20","author":"DeRogatis","year":"2008","journal-title":"Int J Impot Res"},{"key":"2024032600301391900_bb0075","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1743-6109.2009.01309.x","article-title":"Pathways of sexual desire","volume":"6","author":"Pfaus","year":"2009","journal-title":"J Sex Med"},{"key":"2024032600301391900_bb0080","doi-asserted-by":"crossref","first-page":"14602","DOI":"10.1073\/pnas.0606544103","article-title":"Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis","volume":"103","author":"Ag\u00eds-Balboa","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024032600301391900_bb0085","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.tem.2008.07.004","article-title":"Neurosteroids as modulators of neurogenesis and neuronal survival","volume":"19","author":"Charalampopoulos","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"2024032600301391900_bb0090","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1126\/science.2422758","article-title":"Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor","volume":"232","author":"Majewska","year":"1986","journal-title":"Science"},{"key":"2024032600301391900_bb0095","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pharmthera.2007.04.011","article-title":"Neurosteroid regulation of central nervous system development","volume":"116","author":"Mellon","year":"2007","journal-title":"Pharmacol Ther"},{"key":"2024032600301391900_bb0100","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1113\/jphysiol.2008.155655","article-title":"Synaptic integration and plasticity of new neurons in the adult hippocampus","volume":"586","author":"Ge","year":"2008","journal-title":"J Physiol"},{"key":"2024032600301391900_bb0105","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1523\/JNEUROSCI.23-05-01832.2003","article-title":"Perinatal neurosteroid levels influence GABAergic interneuron localization in adult rat prefrontal cortex","volume":"23","author":"Grobin","year":"2003","journal-title":"J Neurosci"},{"key":"2024032600301391900_bb0110","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1460-9568.2002.02084.x","article-title":"The neurosteroid allopregnanolone increases dopamine release and dopaminergic response to morphine in the rat nucleus accumbens","volume":"16","author":"Roug\u00e9-Pont","year":"2002","journal-title":"Eur J Neurosci"},{"key":"2024032600301391900_bb0115","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.pnpbp.2007.09.017","article-title":"Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid","volume":"32","author":"Bishnoi","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2024032600301391900_bb0120","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/dneu.20457","article-title":"Testosterone and dihydrotestosterone, but not estradiol, enhance survival of new hippocampal neurons in adult male rats","volume":"67","author":"Spritzer","year":"2007","journal-title":"Dev Neurobiol"},{"key":"2024032600301391900_bb0125","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1210\/endo.136.4.7534702","article-title":"Dihydrotestosterone is the active androgen in the maintenance of nitric oxide-mediated penile erection in the rat","volume":"136","author":"Lugg","year":"1995","journal-title":"Endocrinology"},{"key":"2024032600301391900_bb0130","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1210\/endo-109-4-1047","article-title":"Attenuation by a 5 alpha-reductase inhibitor of the activational effect of testosterone propionate on penile erections in castrated male rats","volume":"109","author":"Bradshaw","year":"1981","journal-title":"Endocrinology"},{"key":"2024032600301391900_bb0135","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1111\/j.1743-6109.2011.02425.x","article-title":"The effects of chronic 5-alpha-reductase inhibitor (dutasteride) treatment on rat erectile function","volume":"8","author":"Pinsky","year":"2011","journal-title":"J Sex Med"},{"key":"2024032600301391900_bb0140","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/j.1743-6109.2012.02661.x","article-title":"Effects of oral finasteride on erectile function in a rat model","volume":"9","author":"Zhang","year":"2012","journal-title":"J Sex Med"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515337863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515337863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/9\/11\/2927\/47770050\/jsm_9_11_2927.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/9\/11\/2927\/47770050\/jsm_9_11_2927.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T01:23:27Z","timestamp":1711416207000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/9\/11\/2927\/6886761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,1]]},"references-count":27,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2012,11,1]]},"published-print":{"date-parts":[[2012,11,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2012.02846.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2012,11]]},"published":{"date-parts":[[2012,11,1]]}}}